Open Access
Subscription or Fee Access
Budd–Chiari Syndrome: A Critic Review
Abstract
Budd–Chiari syndrome is a very rare condition which is caused by occlusion of the hepatic veins that drain the liver. This condition is fulminant, acute, chronic, or asymptomatic. There are sever important causes, like hepatic vein thrombosis is associated with polycythemia vera, pregnancy, postpartum state, use of oral contraceptives, etc. In this condition, we can see classical triad of abdominal pain, ascites, and liver enlargement, nausea and vomiting, weight loss, vomiting blood, splenomegaly, and edema of the lower limbs. This condition can be treated with surgically like implantating balloon catheter to unblock the hepatic veins, liver transplantation, and also with pharmacologically like anti-clotting medications.
References
Roy PK. Budd–Chiari Syndrome. Available from: https://emedicine.medscape.com/article/184430-overview.
Aydini M, Bayraktar Y. Budd-Chiari syndrome: Etiology, pathogenesis and diagnosis. World J Gastroenterol. 2007; 13(19): 2693–2696p.
National Organization of Rare Disorder (NORD). Budd–Chiari syndrome. Available from: https://rarediseases.org/rare-diseases/budd-chiari-syndrome.
Anssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd-Chiari syndrome: a review by an expert panel. J Hepatol. 2003; 38: 364–371p.
Brancatelli G1, Vilgrain V, Federle MP, Hakime A, Lagalla R, Iannaccone R, Valla D. Budd-Chiari syndrome: spectrum of imaging findings. AJR Am J Roentgenol. 2007; 188(2): W168–W176p. Available from: https://www.
ajronline.org/doi/full/10.2214/AJR.05.0168.
Valla DC. Budd-Chiari syndrome and veno-occlusive disease/sinusoidal obstruction syndrome. Gut. 2008; 57: 1469p.
Menon KV, Shah V, Kamath PS. The Budd-Chiari syndrome. N Engl J Med. 2004; 350: 578p.
Elias E. Pioneering Liver Health. Available from: https://www.
britishlivertrust.org.uk/liver-information/liver-conditions/budd-chiari/.
Rajani R, Melin T, Björnsson E, Broomé U, Sangfelt P, Danielsson A, Gustavsson A, Grip O, Svensson H, Lööf L, Wallerstedt S, Almer SH. [9] Budd–Chiari syndrome in Sweden: epidemiology, clinical characteristics and survival—an 18-year experience. Liver Int. 2009; 29: 253–259p.
Singh J. The portal for rare diseases and orphan drugs. J Pharmacol Pharmacother. 2013; 4(2): 168–169. Available from: https://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=
GB&Expert=131.
https://www.journal-ofhepatology.eu
/action/showFullTableImage?isHtml=true&tableId=TBL1&pii=S0168827802004348
Janssen HL, Garcia-Pagan JC, Elias E, Mentha G, Hadengue A, Valla DC. Budd–Chiari syndrome: a review by an expert panel. J Hepatol. 2003; 38(3): 364–371p.
Orfanidis NT. MSD Manual Consumer Version. Available from: https://www.msdmanuals.com/home/liver-and-gallbladder-disorders/bloo
d-vessel-disorders-of-the-liver/budd-chiari-syndrome.
Uskudar O, Akdogan M, Sasmaz N, Yilmaz S, Tola M, Sahin B. Etiology and portal vein thrombosis in Budd-Chiari syndrome. World J Gastroenterol. 2008; 14(18): 2858–2862p. Available from: https://www.wjgnet.com/1007-9327/full/v14/i18/2858.htm.
Chaudhuri M, Jayaranganath M, Chandra VS. Percutaneous recanalization of an occluded hepatic vein in a difficult subset of pediatric Budd-Chiari syndrome. Pediatr Cardiol. 2012; 33(5): 806–810p.
Mukund A, Sarin SK. Budd-Chiari syndrome: a focussed and collaborative approach. Hepatol Int. 2018; 12(6): 483–486p.
Paradis V, Bièche I, Dargère D, Cazals-Hatem D, Laurendeau I, Saada V, Belghiti J, Bezeaud A, Vidaud M, Bedossa P, Valla DC. Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the disease. Gut. 2005; 54(12): 1776–1781p.
Mahmoud AE1, Mendoza A, Meshikhes AN, Olliff S, West R, Neuberger J, Buckels J, Wilde J, Elias E. Clinical spectrum, investigations and treatment of Budd-Chiari syndrome. QJM. 1996; 89(1): 37–43p.
https://www.amboss.com/us/knowledge/Budd-Chiari_syndrome.
GARD, NIH. Available from: https://rarediseases.info.nih.gov/diseases/5968/budd-chiari-syndrome.
Kane R, Eustace S. Diagnosis of Budd-Chiari syndrome: comparison between sonography and MR angiography. Radiology. 1995; 195: 117–121p.
Stark D, Hahn P, Trey C, Clouse ME, Ferrucci JT Jr. MRI of the Budd-Chiari syndrome. AJR Am J Roentgenol. 1986; 146: 1141–1148p.
Bismuth H, Sherlock D. Portasystemic shunting versus liver transplantation for the Budd-Chiari syndrome. Ann Surg. 1991; 214: 581–589p.
Anticoagulant and Antiplatelet Drugs. Available from: https://www.healthline.com/health/anticoagulant-and-antiplatelet-drugs
https://www.webmd.com/stroke/guide/thrombolysis-definition-and-facts#1.
Darwish Murad S, Valla DC, de Groen PC, Zeitoun G, Hopmans JA, Haagsma EB, van Hoek B, Hansen BE, Rosendaal FR, Janssen HL. Determinants of survival and the effect of portosystemic shunting in patients with Budd–Chiari syndrome. Hepatology. 2004; 39(2): 500–508p.
Rössle M, Richter GM, Nöldge G, Palmaz JC, Wenz W, Gerok W. New non-operative treatment for variceal haemorrhage. Lancet. 1989; 2(8655).
Fisher NC1, McCafferty I, Dolapci M, Wali M, Buckels JA, Olliff SP, Elias E. Managing Budd–Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut. 1999;44(4): 568–574p.
Varma V, Mehta N, Kumaran V. Indications and contraindications for liver transplantation. Int J Hepatol. 2011; 2011: 121862.
Orloff MJ, Daily PO, Orloff SL, Girard B, Orloff MS. A 27-year experience with surgical treatment of Budd–Chiari syndrome. Ann Surg. 2000; 232(3): 340–352p.
Wayne G. (2018). Impaired Tissue Integrity. Available from: https://nurseslabs.com/impaired-tissue-integrity/.
Wayne G. (2016). Imbalanced Nutrition: Less Than Body Requirements. Available from: https://nurseslabs.com/imbalanced-nutrition-less-body-requirements/.
Wayne G. (2016). Hyperthermia. Available from: https://nurseslabs.com/hyperthermia/.
Brunner and Suddarth’s Textbook of Medical Surgical Nursing, Vol. 2, 13th edition. 2000, p. 1279.
DOI: https://doi.org/10.37628/ijncc.v5i2.1281
Refbacks
- There are currently no refbacks.